Synthesis and pharmacological characterization in vitro of cyclic enkephalin analogues: effect of conformational constraints on opiate receptor selectivity.

No abstract is available for this paper.

• Publication year

  1982

• Venue

  Journal of Medicinal Chemistry

• Publication date

  1982-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM00354A008PMID 6296388
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Purification of peptides: an efficient procedure for the separation of peptides from amino acids and salt.

  2009cited by this paper
• Theoretical conformational analysis of enkephalin analogues related to fluorescence and n.m.r. measurements in aqueous solution.

  2009cited by this paper
• A new example of a morphine‐sensitive neuro‐effector junction: Adrenergic transmission in the mouse vas deferens

  1997cited by this paper
• THE ACTION OF MORPHINE AND RELATED SUBSTANCES ON CONTRACTION AND ON ACETYLCHOLINE OUTPUT OF COAXIALLY STIMULATED GUINEA‐PIG ILEUM

  1997cited by this paper
• Opiate receptor subclasses differ in their conformational requirements

  1982cited by this paper
• Analogues of beta-LPH61-64 possessing selective agonist activity at mu-opiate receptors.

  1981cited by this paper
• Evidence of the preferential involvement of mu receptors in analgesia using enkephalins highly selective for peripheral mu or delta receptors.

  1981cited by this paper
• Cyclic enkephalin analogs containing a cystine bridge.

  1981cited by this paper
• D-Tyr--Ser-Gly--Phe--Leu--Thr, a highly preferential ligand for delta-opiate receptors.

  1980cited by this paper
• A cyclic enkephalin analog with high in vitro opiate activity.

  1980cited by this paper
• Selective protection of stereospecific enkephalin and opiate binding against inactivation by N-ethylmaleimide: evidence for two classes of opiate receptors.

  1980cited by this paper
• Brain peptides as neurotransmitters.

  1980cited by this paper
• Specific protection of the binding sites of D-Ala2-D-Leu5- enkephalin (δ-receptors) and dihydromorphine (μ-receptors)

  1979cited by this paper
• Multiple opiate receptors: different regional distribution in the brain and differential binding of opiates and opioid peptides.

  1979cited by this paper
• Opioid activities of fragments of beta-endorphin and of its leucine65-analogue. Comparison of the binding properties of methionine- and leucine-enkephalin.

  1979cited by this paper
• Conformation of [Leu5]enkephalin from X-ray diffraction: features important for recognition at opiate receptor.

  1978cited by this paper
• Unsulfated C-terminal 7-peptide of cholecystokinin: a new ligand of the opiate receptor.

  1978cited by this paper
• The opiate receptor binding interactions of 3H-methionine enkephalin, an opioid peptide.

  1978cited by this paper
• Synthesis, opiate receptor affinity, and conformational parameters of [4-tryptophan]enkephalin analogues.

  1978cited by this paper
• Synthesis of biocytin-containing peptides.

  1977cited by this paper
• Endogenous opioid peptides: multiple agonists and receptors

  1977cited by this paper
• Evidence for topographical analogy between methionine-enkephalin and morphine derivatives.

  1977cited by this paper
• A synthetic enkephalin analogue with prolonged parenteral and oral analgesic activity

  1977cited by this paper
• (D-Ala2)-Met-enkephalinamide: a potent, long-lasting synthetic pentapeptide analgesic.

  1976cited by this paper
• Biosynthetic origin and receptor conformation of methionine enkephalin

  1976cited by this paper
• The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.

  1976cited by this paper
• Proton magnetic resonance studies of conformation and flexibility of enkephalin peptides

  1976cited by this paper
• Conformation of Met5-enkephalin determined by high field PMR spectroscopy

  1976cited by this paper
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper
• Diphenylphosphoryl azide. A new convenient reagent for a modified Curtus reaction and for the peptide synthesis.

  1972cited by this paper
• Kinetic parameters of narcotic agonists and antagonists, with particular reference to N-allylnoroxymorphone (naloxone).

  1968cited by this paper
• A new convenient reagent for peptide syntheses.

  1968cited by this paper
• Polypeptides. V. The use of t-butyl 2,4,5-trichlorophenyl carbonate in the synthesis of N-t-butoxycarbonyl amino-acids and their 2,4,5-trichlorophenyl esters.

  1967cited by this paper
• The availability of the acetyl derivatives of lysine for growth.

  1943cited by this paper

• Analgesic Peptides: From Natural Diversity to Rational Design

  2024cites this paper
• Identification and Pharmacological Characterization of a Low-Liability Antinociceptive Bifunctional MOR/DOR Cyclic Peptide

  2023cites this paper
• C-terminal modified Enkephalin-like tetrapeptides with enhanced affinities at the kappa opioid receptor and monoamine transporters.

  2021cites this paper
• Novel µ opioid antagonists derived from the µ opioid agonists endomorphin and [Dmt1]DALDA (H‐Dmt‐D‐Arg‐Phe‐Lys‐NH2)

  2020cites this paper
• Toward a Universal μ-Agonist Template for Template-Based Alignment Modeling of Opioid Ligands

  2019cites this paper
• Solid-Phase Azopeptide Diels-Alder Chemistry for Aza-pipecolyl Residue Synthesis To Study Peptide Conformation.

  2019cites this paper
• Efficient Synthesis of Norbuprenorphines Coupled with Enkephalins and Investigation of Their Permeability

  2019cites this paper
• Analgesic Properties of Opioid/NK1 Multitarget Ligands with Distinct in Vitro Profiles in Naive and Chronic Constriction Injury Mice.

  2017cites this paper
• Highly Constrained Bicyclic Scaffolds for the Discovery of Protease-Stable Peptides via mRNA Display.

  2017cites this paper
• A Cyclic Tetrapeptide ("Cyclodal") and Its Mirror-Image Isomer Are Both High-Affinity μ Opioid Receptor Antagonists.

  2016cites this paper
• Bifunctional Peptide-Based Opioid Agonist-Nociceptin Antagonist Ligands for Dual Treatment of Acute and Neuropathic Pain.

  2016cites this paper
• Synthesis of Met‐enkephalin by solution‐phase peptide synthesis methodology utilizing para‐toluene sulfonic acid as N‐terminal masking of l‐methionine amino acid

  2016cites this paper
• Peptide and peptide library cyclization via bromomethylbenzene derivatives.

  2015cites this paper
• Synthesis and biological evaluation of compact, conformationally constrained bifunctional opioid agonist - neurokinin-1 antagonist peptidomimetics.

  2015cites this paper
• Cyclic endomorphin analogs in targeting opioid receptors to achieve pain relief.

  2014cites this paper
• [Dmt(1)]DALDA analogues with enhanced μ opioid agonist potency and with a mixed μ/κ opioid activity profile.

  2014cites this paper
• Cyclic pentapeptide analogs based on endomorphin-2 structure: cyclization studies using liquid chromatography combined with on-line mass spectrometry and tandem mass spectrometry.

  2014cites this paper
• 'Carba'-carfentanil (trans isomer): a μ opioid receptor (MOR) partial agonist with a distinct binding mode.

  2014cites this paper
• Synthesis, biological activity and resistance to proteolytic digestion of new cyclic dermorphin/deltorphin analogues.

  2013cites this paper
• Cyclic enkephalins with a diversely substituted guanidine bridge or a thiourea bridge: synthesis, biological and structural evaluations.

  2013cites this paper
• Cyclization in opioid peptides.

  2013cites this paper
• Preparation and evaluation at the delta opioid receptor of a series of linear leu-enkephalin analogues obtained by systematic replacement of the amides.

  2013cites this paper
• In vivo antinociception of potent mu opioid agonist tetrapeptide analogues and comparison with a compact opioid agonist - neurokinin 1 receptor antagonist chimera

  2012cites this paper
• Neural and Endocrine Peptides and Receptors

  2012cites this paper
• Bifunctional μ/δ Opioid Peptides: Variation of the Type and Length of the Linker Connecting the Two Components

  2012cites this paper
• Activity Profiles of Linear, Cyclic Monomer and Cyclic Dimer of Enkephalin

  2012cites this paper
• Variation of the net charge, lipophilicity, and side chain flexibility in Dmt(1)-DALDA: Effect on Opioid Activity and Biodistribution.

  2012cites this paper
• Solvatochromic reagents for multicomponent reactions and their utility in the development of cell-permeable macrocyclic peptide vectors.

  2011cites this paper
• Design of novel neurokinin 1 receptor antagonists based on conformationally constrained aromatic amino acids and discovery of a potent chimeric opioid agonist-neurokinin 1 receptor antagonist.

  2011cites this paper
• Synthesis of an Enkephalin Analogue Containing an α,α-Disubstituted Heterocyclic Aminophosphonic Acid

  2011cites this paper
• "Carba"-analogues of fentanyl are opioid receptor agonists.

  2010cites this paper
• N‐Methylated Cyclic Enkephalin Analogues Retain High Opioid Receptor Binding Affinity

  2010cites this paper
• Structure-Activity Relationships of 13- and 14-Membered Cyclic Partial Retro-Inverso Pentapeptides Related to Enkephalin

  2010cites this paper
• Synthesis of side-chain to side-chain cyclized peptide analogs on solid supports

  2009cites this paper
• Morphiceptin analogs containing 2-aminocyclopentane carboxylic acid as a peptidomimetic for proline.

  2009cites this paper
• Synthesis of cyclic dipeptide templates, their incorporation into peptides and studies on their conformational and biological properties.

  2009cites this paper
• Methionine-enkephalin related glycoconjugates. Synthesis and biological activity.

  2009cites this paper
• Peptide conformations. 33. Conformational analysis of cyclic enkephalin analogs of the type Tyr‐cyclo‐(‐N ω ‐Xxx‐Gly‐Phe‐Leu‐)*

  2009cites this paper
• Cyclization studies with tetra- and pentapeptide sequences corresponding to beta-casomorphins.

  2009cites this paper
• Biological and conformational studies of [Val4]morphiceptin and [D-Val4]morphiceptin analogs incorporating cis-2-aminocyclopentane carboxylic acid as a peptidomimetic for proline.

  2009cites this paper
• Aladan scanning: The structure-activity relationship of dynorphin A

  2009cites this paper
• The receptor-bound conformation of H-Tyr-Tic-(Phe-Phe)-OH-related delta-opioid antagonists contains all trans peptide bonds.

  2009cites this paper
• Applications of BOP reagent in solid phase synthesis. II: Solid phase side-chain to side-chain cyclizations using BOP reagent

  2009cites this paper
• Effect of aromatic amino acid substitutions in the 3‐position of cyclic β‐casomorphin analogues on μ‐opioid agonist/δ‐opioid antagonist properties*

  2009cites this paper
• Synthesis and biological activity of some glucose-enkephalin conjugates.

  2009cites this paper
• Acetylated glucopyranosyl esters of enkephalins.

  2009cites this paper
• Cyclic Opioid Peptide Agonists and Antagonists Obtained Via Ring‐Closing Metathesis

  2009cites this paper
• Structure-activity relationships of dermorphin analogues containing N-substituted amino acids in the 2-position of the peptide sequence.

  2009cites this paper
• Synthesis and biological activity of linear and cyclic enkephalins modified at the Gly3‐Phe4amide bond

  2009cites this paper
• Synthesis of 17O isotope labeled Leu-enkephalin and 17O n.m.r.

  2009cites this paper
• Conformational features responsible for binding of cyclic analogues of enkephalin to opioid receptors. I. Low-energy peptide backbone conformers of analogues containing Phe4.

  2009cites this paper
• Solvent dependent conformational statistics of enkephalin and angiotensin II.

  2009cites this paper
• Cyclic morphiceptin analogs: cyclization studies and opioid activities in vitro.

  2009cites this paper
• Direct electrophilic fluorination of tyrosine in dermorphin analogues and its effect on biological activity, receptor affinity and selectivity.

  2009cites this paper
• Synthesis of novel peptide linkers: simultaneous cyclization and labeling.

  2009cites this paper
• 14-membered cyclic opioids related to dermorphin and their partially retro-inverso modified analogues. I. Synthesis and biological activity.

  2009cites this paper
• Synthesis and biological activity of [Leu5]enkephalin derivatives containing D-glucose.

  2009cites this paper
• Conformational features responsible for the binding of cyclic analogues of enkephalin to opioid receptors. II. Models of mu- and delta-receptor-bound structures for analogues containing Phe4.

  2009cites this paper
• Cyclization studies with a model pentapeptide.

  2009cites this paper
• Blood-brain barrier penetration by two dermorphin tetrapeptide analogues: role of lipophilicity vs structural flexibility.

  2008cites this paper
• Multiple ligands in opioid research.

  2008cites this paper
• Cyclic enkephalin analogs containing various para-substituted phenylalanine derivatives in place of Tyr1 are potent opioid agonists.

  2008cites this paper
• Conformational constraint in protein ligand design and the inconsistency of binding entropy.

  2008cites this paper
• Potent Opioid Peptide Agonists Containing 4′‐[N‐((4′‐phenyl)‐phenethyl)carboxamido]phenylalanine (Bcp) in Place of Tyr

  2008cites this paper
• Synthesis of stable and potent delta/mu opioid peptides: analogues of H-Tyr-c[D-Cys-Gly-Phe-D-Cys]-OH by ring-closing metathesis.

  2007cites this paper
• Synthesis of 4-amino-3-oxo-tetrahydroazepino[3,4-b]indoles: new conformationally constrained Trp analogs

  2007cites this paper
• Synthesis and Characterization of Potent and Selective μ-Opioid Receptor Antagonists, [Dmt1, d-2-Nal4]endomorphin-1 (Antanal-1) and [Dmt1, d-2-Nal4]endomorphin-2 (Antanal-2)

  2007cites this paper
• Development of novel enkephalin analogues that have enhanced opioid activities at both mu and delta opioid receptors.

  2007cites this paper
• Synthesis and characterization of potent and selective mu-opioid receptor antagonists, [Dmt(1), D-2-Nal(4)]endomorphin-1 (Antanal-1) and [Dmt(1), D-2-Nal(4)]endomorphin-2 (Antanal-2).

  2007cites this paper
• Dicarba analogues of the cyclic enkephalin peptides H-Tyr-c[D-Cys-Gly-Phe-D(or L)-Cys]NH(2) retain high opioid activity.

  2007cites this paper
• Formation Pathways and Opioid Activity Data for 3‐Hydroxypyridinium Compounds Derived from Glucuronic Acid and Opioid Peptides by Maillard Processes

  2007cites this paper
• Beta-methyl substitution of cyclohexylalanine in Dmt-Tic-Cha-Phe peptides results in highly potent delta opioid antagonists.

  2007cites this paper
• Cyclic dermorphin tetrapeptide analogues obtained via ring-closing metathesis.

  2006cites this paper
• Design, synthesis, and biological evaluation of new cyclic melanotropin peptide analogues selective for the human melanocortin-4 receptor.

  2006cites this paper
• Consequences of cis-amide bond simulation in opioid peptides

  2006cites this paper
• Synthesis and biological evaluation of constrained analogues of the opioid peptide H-Tyr-D-Ala-Phe-Gly-NH2 using the 4-amino-2-benzazepin-3-one scaffold.

  2005cites this paper
• Synthesis of Novel Biologically Active Peptide Analogues that are Agonists at Opioid Receptors and Antagonists at Cholecystokinin Receptors

  2005cites this paper
• Synthesis and biological activity profile of new analogues of the cyclic opioid peptide H‐Tyr‐c[D‐Cys‐Gly‐Phe(pNO2)‐D‐Cys]‐NH2 containing (S)‐α‐hydroxymethylcysteine in place of cysteine

  2005cites this paper
• A new structural motif for mu-opioid antagonists.

  2005cites this paper
• Conformationally restricted peptides as tools in opioid receptor studies.

  2005cites this paper
• [Aladan3]TIPP: A fluorescent δ‐opioid antagonist with high δ‐receptor binding affinity and δ selectivity

  2005cites this paper
• Type and location of fluorescent probes incorporated into the potent mu-opioid peptide [Dmt]DALDA affect potency, receptor selectivity and intrinsic efficacy.

  2005cites this paper
• Use of NMR and fluorescence spectroscopy as well as theoretical conformational analysis in conformation-activity studies of cyclic enkephalin analogues.

  2004cites this paper
• The design and synthesis of novel beta-substituted amino acids, bicyclic dipeptide mimetics, and their incorporation into cholecystokinin/opioidchimeric peptides

  2004cites this paper
• A chimeric opioid peptide with mixed μ agonist/δ antagonist properties

  2004cites this paper
• Opioid receptors and their ligands.

  2004cites this paper
• Dansylated analogues of the opioid peptide [Dmt1]DALDA: in vitro activity profiles and fluorescence parameters.

  2004cites this paper
• Vibrational analysis of capped [Leu]enkephalin

  2004cites this paper
• A chimeric opioid peptide with mixed mu agonist/delta antagonist properties.

  2004cites this paper
• An Improved Preparation of N 2‐tert‐Butoxycarbonyl‐ and N 2‐Benzyloxy‐carbonyl‐(S)‐2,4‐diaminobutanoic Acids

  2004cites this paper
• Endogenous Peptides for Delta Opioid Receptors and Analogues

  2003cites this paper
• Potent side‐chain to side‐chain cyclized dermorphin analogues containing a carbonyl bridge

  2003cites this paper
• Glycopeptide-membrane interactions: glycosyl enkephalin analogues adopt turn conformations by NMR and CD in amphipathic media.

  2003cites this paper
• Highly potent fluorescent analogues of the opioid peptide [Dmt1] DALDA.

  2003cites this paper
• Structure-activity relationship, conformation and pharmacology studies of morphiceptin analogues--selective mu-opioid receptor ligands.

  2002cites this paper
• Bioactive pseudopeptidic analogues and cyclostereoisomers of osteogenic growth peptide C-terminal pentapeptide, OGP(10-14).

  2002cites this paper
• Synthesis and biological activities of cyclic lanthionine enkephalin analogues: delta-opioid receptor selective ligands.

  2002cites this paper
• Pseudoproline-containing analogues of morphiceptin and endomorphin-2: evidence for a cis Tyr-Pro amide bond in the bioactive conformation.

  2001cites this paper
• Fluorescence decay time distribution analysis of cyclic enkephalin analogues; influence of solvent and Leu configuration in position 5 on conformation.

  2001cites this paper
• DALDA analogues containing alpha-hydroxymethylamino acids.

  2001cites this paper